TN SB1423 | 2017-2018 | 110th General Assembly

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 9 2017 - 25% progression, died in committee
Action: 2017-02-13 - Passed on Second Consideration, refer to Senate Commerce and Labor Committee
Pending: Senate Commerce and Labor Committee
Text: Latest bill text (Draft #1) [PDF]

Summary

As introduced, requires certain drug manufacturers to submit information to the department of health about drug prices; requires the department of commerce and insurance to promulgate rules relating to disclosure of drug formulary prices. - Amends TCA Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

As introduced, requires certain drug manufacturers to submit information to the department of health about drug prices; requires the department of commerce and insurance to promulgate rules relating to disclosure of drug formulary prices. - Amends TCA Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71.

Sponsors


History

DateChamberAction
2017-02-13SenatePassed on Second Consideration, refer to Senate Commerce and Labor Committee
2017-02-09SenateIntroduced, Passed on First Consideration
2017-02-09SenateFiled for introduction

Same As/Similar To

HB1327 (Crossfiled) 2017-02-17 - Assigned to s/c Insurance and Banking Subcommittee

Subjects


Tennessee State Sources


Bill Comments

feedback